AlloVir, Inc.
NASDAQ:ALVR
0.619 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0.165 | 1.135 |
| Cost of Revenue
| 0.398 | 2.565 | 1.117 | 0.073 | 0 | 0 |
| Gross Profit
| -0.398 | -2.565 | -1.117 | -0.073 | 0.165 | 1.135 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 1 | 1 |
| Reseach & Development Expenses
| 133.07 | 118.87 | 120.735 | 49.663 | 16.248 | 1.7 |
| General & Administrative Expenses
| 48.261 | 52.332 | 49.083 | 21.646 | 10.618 | 3.031 |
| Selling & Marketing Expenses
| 48.213 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 48.261 | 52.332 | 49.083 | 21.646 | 10.618 | 3.031 |
| Other Expenses
| 18.57 | 0.351 | -2.452 | 0.195 | 0.797 | 1.11 |
| Operating Expenses
| 196.278 | 171.202 | 169.818 | 71.309 | 26.866 | 4.731 |
| Operating Income
| -181.331 | -171.202 | -169.818 | -71.309 | -26.701 | -3.596 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | -161.824 | -3.168 |
| Total Other Income Expenses Net
| -9.213 | 2.227 | -1.137 | 1.525 | 2.862 | 1.11 |
| Income Before Tax
| -190.544 | -168.975 | -170.955 | -69.784 | -23.839 | -2.43 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | -144.479 | -2.141 |
| Income Tax Expense
| 0.126 | -0.265 | 1.007 | -1.403 | -2.065 | 1.166 |
| Net Income
| -190.418 | -168.71 | -171.962 | -68.381 | -21.774 | -2.43 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | -131.964 | -2.141 |
| EPS
| -1.83 | -2.2 | -2.74 | -2.54 | -0.33 | -0.066 |
| EPS Diluted
| -1.83 | -2.2 | -2.74 | -2.54 | -0.33 | -0.066 |
| EBITDA
| -180.933 | -171.202 | -169.818 | -71.309 | -26.682 | -3.596 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | -161.709 | -3.168 |